Guan G, Fu Z, Zhang D, Guo Y, Guo F, Wan Y
World J Oncol. 2024; 15(6):929-941.
PMID: 39697423
PMC: 11650609.
DOI: 10.14740/wjon1994.
SoRelle E, Haynes L, Willard K, Chang B, Chng J, Christofk H
PLoS Pathog. 2024; 20(10):e1012341.
PMID: 39446925
PMC: 11563402.
DOI: 10.1371/journal.ppat.1012341.
Liu H, Wang J, Wang L, Tang W, Hou X, Zhu Y
Biomolecules. 2024; 14(9).
PMID: 39334908
PMC: 11430640.
DOI: 10.3390/biom14091142.
Zeng S, Li X, Liu Y, Huang Q, He Y
Bioengineering (Basel). 2024; 11(7).
PMID: 39061821
PMC: 11273917.
DOI: 10.3390/bioengineering11070739.
SoRelle E, Haynes L, Willard K, Chang B, Chng J, Christofk H
bioRxiv. 2024; .
PMID: 38915538
PMC: 11195279.
DOI: 10.1101/2024.06.14.598975.
Current and Emerging Diagnostic, Prognostic, and Predictive Biomarkers in Head and Neck Cancer.
Eberly H, Sciscent B, Lorenz F, Rettig E, Goyal N
Biomedicines. 2024; 12(2).
PMID: 38398017
PMC: 10886579.
DOI: 10.3390/biomedicines12020415.
EBV DNA methylation profiles and its application in distinguishing nasopharyngeal carcinoma and nasal NK/T-cell lymphoma.
Tang C, Li X, Zhou T, Deng C, Jiang C, Zhang Y
Clin Epigenetics. 2024; 16(1):11.
PMID: 38212818
PMC: 10785554.
DOI: 10.1186/s13148-024-01624-y.
The master antioxidant defense is activated during EBV latent infection.
Wang L, Howell M, Hensley C, Ning K, Moorman J, Yao Z
J Virol. 2023; 97(11):e0095323.
PMID: 37877721
PMC: 10688347.
DOI: 10.1128/jvi.00953-23.
Anoikis resistance and immune escape mediated by Epstein-Barr virus-encoded latent membrane protein 1-induced stabilization of PGC-1α promotes invasion and metastasis of nasopharyngeal carcinoma.
Liao C, Li M, Chen X, Tang C, Quan J, Bode A
J Exp Clin Cancer Res. 2023; 42(1):261.
PMID: 37803433
PMC: 10559433.
DOI: 10.1186/s13046-023-02835-6.
Association of Nasopharynx Cancer with Human Papillomavirus Infections.
Hung S, Yang T, Cheng Y, Chen C, Lin H
Cancers (Basel). 2023; 15(16).
PMID: 37627110
PMC: 10452438.
DOI: 10.3390/cancers15164082.
Recurrent/Metastatic Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Heading?.
Juarez-Vignon Whaley J, Afkhami M, Onyshchenko M, Massarelli E, Sampath S, Amini A
Curr Treat Options Oncol. 2023; 24(9):1138-1166.
PMID: 37318724
PMC: 10477128.
DOI: 10.1007/s11864-023-01101-3.
Impact of Epstein Barr Virus Infection on Treatment Opportunities in Patients with Nasopharyngeal Cancer.
Perri F, Sabbatino F, Ottaiano A, Fusco R, Caraglia M, Cascella M
Cancers (Basel). 2023; 15(5).
PMID: 36900413
PMC: 10000842.
DOI: 10.3390/cancers15051626.
Protein Kinase CK2 and Epstein-Barr Virus.
Montenarh M, Grasser F, Gotz C
Biomedicines. 2023; 11(2).
PMID: 36830895
PMC: 9953236.
DOI: 10.3390/biomedicines11020358.
MRGBP: A New Factor for Diagnosis and Prediction of Head and Neck Squamous Cell Carcinoma.
Zhao C, Wei C, Chen X, Li P
Biomed Res Int. 2022; 2022:7281120.
PMID: 35924262
PMC: 9343194.
DOI: 10.1155/2022/7281120.
Extracellular Vesicles in the Progression and Therapeutic Resistance of Nasopharyngeal Carcinoma.
Shan Y, Zhou P, Zhou Q, Yang L
Cancers (Basel). 2022; 14(9).
PMID: 35565418
PMC: 9101631.
DOI: 10.3390/cancers14092289.
Environmental Factors for Epstein-Barr Virus Reactivation in a High-Risk Area of Nasopharyngeal Carcinoma: A Population-Based Study.
Chen Y, Chang E, Liu Q, Cai Y, Zhang Z, Chen G
Open Forum Infect Dis. 2022; 9(5):ofac128.
PMID: 35450082
PMC: 9017372.
DOI: 10.1093/ofid/ofac128.
Design of InnoPrimers-Duplex Real-Time PCR for Detection and Treatment Response Prediction of EBV-Associated Nasopharyngeal Carcinoma Circulating Genetic Biomarker.
Abusalah M, Binti Hassan S, Mat Lazim N, Abdullah B, Wan Sohaimi W, Husin A
Diagnostics (Basel). 2021; 11(10).
PMID: 34679459
PMC: 8534743.
DOI: 10.3390/diagnostics11101761.
Radiotherapy Combined with PD-1 Inhibition Increases NK Cell Cytotoxicity towards Nasopharyngeal Carcinoma Cells.
Makowska A, Lelabi N, Nothbaum C, Shen L, Busson P, Tran T
Cells. 2021; 10(9).
PMID: 34572108
PMC: 8470143.
DOI: 10.3390/cells10092458.
Epstein-Barr Virus Latent Membrane Protein-1 Expression in Nasopharyngeal Carcinoma.
Salano V, Mwakigonja A, Abdulshakoor A, Kahinga A, Richard E
JCO Glob Oncol. 2021; 7:1406-1412.
PMID: 34546798
PMC: 8457857.
DOI: 10.1200/GO.21.00120.
Simultaneously Both Expression of and Methylation of : Molecular Biomarker in Stage IV of Nasopharyngeal Carcinoma Patients.
Lao T, Truong P, Thieu H, Nguyen D, Nguyen M, Le T
Balkan J Med Genet. 2021; 24(1):57-66.
PMID: 34447660
PMC: 8366468.
DOI: 10.2478/bjmg-2021-0005.